Nanogen, Hoechst AG deal

NGEN and Hoechst affiliate Aventis Research and Technologies (Frankfurt, Germany) extended their 1997 research agreement to three years from two, for which NGEN will receive additional funding. The companies are developing microarray platforms combining NGEN's semiconductor microchip technology with Aventis' technologies in drug screening and development. ...